| Literature DB >> 31017485 |
Tommaso Filippini1, Elizabeth E Hatch2, Kenneth J Rothman2,3, Julia E Heck4, Andrew S Park4, Alessio Crippa5, Nicola Orsini6, Marco Vinceti1,2.
Abstract
BACKGROUND: A causal link between outdoor air pollution and childhood leukemia has been proposed, but some older studies suffer from methodological drawbacks. To the best of our knowledge, no systematic reviews have summarized the most recently published evidence and no analyses have examined the dose-response relation.Entities:
Year: 2019 PMID: 31017485 PMCID: PMC6785230 DOI: 10.1289/EHP4381
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1.Flowchart of literature search and identification through 20 March 2019.
Main characteristics of case–control and cohort studies on air pollution from motorized traffic and risk of childhood leukemia.
| Reference | Region | Study period | Type of cancer | Cases/controls | Age (y) | Exposure assessment | Methods | Type of residence | Case selection | Control selection | Matching variables | Adjustment factors |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Malaysia | 2001–2007 | All leukemias | 128/128 | 0–14 | Traffic density | Traffic density using distance from main road | Residence at diagnosis | Histological confirmed diagnosis of acute leukemia in two Malaysian hospitals | Hospital selection from children received treatment in one of the two hospitals | None | Family income, paternal social contact, number of elder siblings, maternal age, paternal age, family history of cancer, paternal smoking, distance to main road, and distance to power line | |
| France | 2003–2004 | All leukemias ( | 763 | 0–14 | Traffic density estimated using three models and a composite of them, including | Traffic density through proximity to main roads within area of | Residence at diagnosis | French National Cancer Registry of Childhood Hematopoietic Malignancies | Community recruitment with telephone interviews. Response rates for case/controls of 91% and 71% | Sex and age | Sex, age, and socioeconomic status | |
| Italy | 1998–2001 | All leukemias | 747/1,509 | 0–10 (0–4) | Traffic density using two models and pollutants exposure ( | Traffic density using distance from main roads ( | Residence at birth | Italian Association of Pediatric Hematology and Oncology Registry | Community selection with face-to-face not-blinded interview. Response rates for case/controls of 91.4% and 69.2% | Sex and age | Sex, age, region of residence and parental education level | |
| Italy | 1978–1997 | All leukemias and ALL | 120/480 | 0–14 | Traffic density using distance from major roads and benzene exposure | Distance from major roads ( | Residence at diagnosis | Lombardy Cancer Registry | Community selection by Health Services archives of Varese | Sex and birth year | Sex, age, and socioeconomic status | |
| Sweden | 1960–1985 | All leukemias | 39/151 | 0–15 | Residence for at least 1 y within | Swedish Cancer Registry linking medical records to verify diagnoses | Community selection from same area | Age, municipality and residence near the same high voltage power lines | Magnetic fields and socioeconomic status | |||
| California | 1988–2008 | 0–5 | NO, | Pollutant exposures estimated using LUR, unseasonalized, and seasonalized models | Residence at birth | California Cancer Registry | Community selection from birth certificates from mothers living in Los Angeles County | Sex and birth year | Sex, birth year, race/ethnicity, maternal education level, parity, prenatal care insurance type, and neighborhood socioeconomic index | |||
| United Kingdom | 1990–1994 | All leukemias | 130/251 | 0–15 | Traffic density as measured by weighted distance from major roads | Addresses within | Residence at diagnosis | West Midland Cancer Intelligence Units, using ICD-9 | Solid tumor cases from the same register as the cases | None | None | |
| California | 1998–2007 | 0–5 | Traffic density, CO, and | Traffic density in vehicles per day within | Residence at birth | California Cancer Registry | Community selection from birth certificates | Birth year | Birth year, maternal race/ethnicity, mother’s birth place, and neighborhood socioeconomic index | |||
| California | 1990–2007 | 0–6 | Air toxic exposure | Pollutant exposures (total PAHs, benzene, ethyl-benzene, 1,3-butadiene) taken from air monitors within 2 or | Residence at birth | California Cancer Registry | Community selection from birth certificates | Birth year | Birth year, maternal race/ethnicity, mother’s birth place, and neighborhood socioeconomic index | |||
| France | 2002–2007 | All leukemias ( | 2,760 | 0–14 (0–4, 5–9, 10–14) | Traffic density estimated using two models, | Traffic density through proximity to major roads within area of | Residence at diagnosis | French National Cancer Registry of Childhood Hematopoietic Malignancies | Community selection from National Institute for Statistics and Economic Studies | None | Age (and deprivation index only in road length analysis) | |
| Oklahoma | 1997–2012 | All leukemias ( | 307 | 0–19 (0–4, 5–9, 10–14, 15–19) | Traffic density using two models and | Traffic density through proximity to major roads within area of 750 or | Residence at birth | Oklahoma Central Cancer Registry | Community selection from birth certificates | Birth week | Age, maternal education (and urbanization) | |
| Oklahoma | 1997–2012 | All leukemias ( | 307 | 0–19 (0–4, 5–9, 10–14, 15–19) | Benzene exposure | Benzene exposure levels based on National-Scale Air to Toxics Assessment (NATA) 2005 models | Residence at birth | Oklahoma Central Cancer Registry | Community selection from birth certificates | Birth week | Age, maternal education and urbanization | |
| California | 1978–1984 | All leukemias | 212/202 | 0–10 | Traffic density as vehicles per day estimated in two models | Traffic density at the longest-lived residence for all streets within 1,500-ft radius, divided into three categories ( | Residence of longest duration | Los Angeles Country Cancer Registry | Community selection by not-blinded telephone interviews with random digit dialing method | Sex and age | Wire-code | |
| Ontario, Canada | 1988–2012 | All leukemias ( | 941 ( | 0–5 | Land-use regression model estimates of | Residence at birth | Pediatric Oncology Group of Ontario Networked Information System | Mother–baby Linked database of hospital admission records of deliveries across Ontario | Not applicable | Age at delivery, infant sex, parity, year of birth, maternal cigarette smoking during pregnancy, census tract median family income, census tract proportion of population who are visibly minority, and census tract proportion of the adult female population 25–64 y of age who completed postsecondary education | ||
| Italy | 1998–2001 | All leukemias ( | 648 ( | 0–10 | Traffic density using main roads’ length | Traffic density using main roads’ length within area of | Residence at birth Residence of longest duration Residence for at least 50% of life Residence considered the highest exposed | Italian Association of Pediatric Hematology and Oncology Registry | Community selection with face-to-face not-blinded interview. Response rates for case/controls of 91.7% and 70.8% | Sex, age, and region | Sex, age, region, parental education, and parental smoking | |
| Colorado | 1978–1983 | All leukemias | 97/259 | 0–14 | Traffic density in vehicles per day estimated in highest vs. lowest category: two different models | Traffic density within 750-ft distance-weighted traffic density using six categories: | Residence at diagnosis | Colorado Central Cancer Registry | Community selection by not-blinded telephone interviews with random digit dialing method | Sex, age, and telephone exchange area | None | |
| Denmark | 1968–1991 | All leukemias | 986/5,506 | 0–14 | Traffic density as vehicles per day, and pollutant (benzene and | Traffic density estimated in vehicles/day using four categories: | Residence at diagnosis | Danish Cancer Registry | Danish Central Population Registry | Sex, age, and calendar time | Urban development, geographic region, type of residence, electromagnetic fields, mother’s age, and birth order | |
| Denmark | 1968–1991 | 0–14 | Benzene exposure during childhood and pregnancy | Pollution Model and 50th and 90th percentiles as cutoff points resulted in three categories for benzene during childhood ( | Residence at diagnosis | Danish Cancer Registry | Danish Central Population Registry | Sex, age, and calendar time | Degree of urbanization, geographic region, type of residence, electromagnetic fields, mother’s age, and birth order | |||
| California | 1988–1994 | All leukemias | 90/349 | 0–5 | Traffic density using average number of cars per day (ADT) | ADT of road segments within a 550-ft radius from home address and divided into three categories: no ADT (reference), | Residence at birth | California Cancer Registry | Community selection from birth certificates | Sex and birth year | Sex, birth year, ethnicity, and median child family income | |
| California | 1988–1997 | All leukemias (and ALL) | 1,728 (1,407)/3,456 | 0–4 | Traffic density and road density | Traffic density using combination of road length and vehicle traffic counts. Road density: summary of total road length (in miles per square mile) within 500-ft radius. For both, 25th, 50th, 75th, and 90th percentiles were used as cut points | Residence at birth | California Cancer Registry | Community selection from birth certificates | Sex and birth year | Sex, birth year, and ethnicity | |
| Colorado | 1976–1983 | All leukemias (and ALL) | 98 (79)/262 | 0–14 (0–4, 5–14) | Traffic density in vehicles per day estimated in four different models | Traffic density at the address of residence using street maps of Denver Standard Metropolitan Statistical Area: vehicles/day divided into two or three categories: | Residence at diagnosis | Colorado Central Cancer Registry | Community recruitment by random digit dial, data collection via telephone interview. Overall response rate of 75% | Sex, age, and telephone exchange area | Sex, age, year of diagnosis, type of residence, location at birth, mother’s age, father’s education, and per capita income and wire configuration code at diagnosis | |
| Switzerland | 1990–2008 | All leukemias (and ALL) | 532 (416)/2,096,402 (total cohort) | 0–15 (0–4) | Distance from heavy traffic roads | Distance to the nearest highway ( | Residence at diagnosis | Swiss Childhood Cancer Registry | Swiss resident population | Not applicable | Sex, birth year, urbanization, socioeconomic position, educational level of household head, number of persons per room, nationality, background ionizing radiation (terrestrial gamma and cosmic rays), distance to the nearest power line, and strength of electromagnetic fields from broadcast transmitters | |
| France | 1995–1999 | All leukemias ( | 280 | 0–14 | Traffic density using main roads’ density | Traffic density using presence of heavy traffic roads within | Residence at diagnosis | Hospitals of Nancy, Lille, Lyon, and Paris | Hospital recruitment with face-to-face interviews to assess exposure | Sex, age, ethnic origin, and hospital | Sex, age, ethnic origin, and hospital | |
| Texas | 1995–2011 | ALL | 1,248/12,172 | 0–4 | Benzene, 1,3-butadiene and POM exposure | Air pollutants (benzene, 1,3-butadiene, and POM) exposure levels based on 1996, 1999, 2002, and 2005 NATA models | Residence at birth | Texas Cancer Registry | Community controls from Texas Department of State Health Services vital statistics birth records | Birth year and month | Birth year and month, air pollutants (benzene, 1,3-butadiene, POM), census tract, maternal age, infant birth weight, sex, and maternal race/ethnicity | |
| Spain | 1996–2011 | All leukemias ( | 1,061 | 0–14 | Traffic density using annual average daily traffic and distance to busy roads | Traffic density using Navteq software function to characterize road classes, their proximity and traffic density within multiple buffers (50, 100, 200, and | Residence at diagnosis for cases, at birth for controls | Spanish Registry of Childhood Tumours (RETI-SEHOP) | Community controls from Birth Registry of the Spanish Statistical Office | Sex, birth year, and, autonomous region of residence | Sex, birth year, autonomous region of residence, socioeconomic status, industrial pollution, and crop exposure | |
| Italy | 1998–2009 | All leukemias ( | 83 | 0–14 (0–5, 5–14) | Benzene and | Average and maximum hourly levels of benzene and | Residence at diagnosis | Italian Association of Pediatric Hematology and Oncology Registry | Community selection from Local Health Units of Modena and Reggio Emilia | Sex, birth year, and province of residence | Benzene and | |
| Netherlands | 1989–1997 | ALL | 5/total population | 0–14 | Traffic density as residence along busiest main roads | Traffic density measured as residence along main roads with traffic identity score | Residence at 1998 or date of death | Amsterdam Cancer Registry | Amsterdam resident population | Not applicable | 5-y-of-age group and sex-specific standardized incidence rate | |
| California | 1995–2002 | ALL | 310/396 | 0–15 | Traffic density in total vehicle miles traveled per square mile | Traffic density in total vehicle miles traveled per square mile within 500-ft radius using 0th, 50th, and 75th percentiles as cut points (no roads, 1–38,499, 38,500–91,461, | Residence at birth, at diagnosis and the average lifetime | Hospitals participating in Northern California Childhood Leukemia Study | Community selection from birth certificates. Participation rates for cases/controls of 86% and 84%. | Sex, age, Hispanic ethnicity, and mother’s race | Sex, age, Hispanic ethnicity, mother’s race, and household income category | |
| Taiwan | 1995–2005 | All leukemias | 308/308 | 0–14 | Place of usual residence indicated in death certificate | Death certificates using ICD codes | Death certificates | Sex, birth year, and death year | Socioeconomic status |
Note: Metric conversion factors: 1 foot = 0.3048 meter; 1 mile = 1,609.34 meters. ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; ANLL, acute non-lymphoblastic leukemia; CALINE, California line source dispersion model; CO, carbon monoxide; LUR, land-use regression; NATA, National-Scale Air to Toxics Assessment; NO, nitric oxide; , nitrogen dioxide, , nitrogen oxides; , ozone; PAH, polycyclic aromatic hydrocarbons; PM, particulate matter; POM, polycyclic organic matter.
Figure 2.Characteristics of included studies according to traffic pollution assessment, and other characteristics. Composite index, combination of various measures of traffic density; D, residential address retrieved from death certificate; distance, distance between the residence and a major road; , nitrogen dioxide; PM, particulate matter; road density, sum of the length of roads within a defined area around the residence; traffic count, estimated number of vehicles per day in the roads within a defined distance from the residence. For population-based studies, we indicated whether exposure assessment depended upon acceptance to participate in the study (voluntary) or it was based solely on residential address, without contacting the participants (involuntary).
Summary risk ratios (RRs) of childhood leukemia in the highest exposure category versus the lowest one for traffic density, benzene, and nitrogen dioxide () exposure, for all studies and stratified by age at diagnosis, leukemia subtype, exposure timing, and region.
| All children | Preschool children ( | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indicator | RR | 95% CI | RR | 95% CI | RR | 95% CI | |||||||||
| Traffic density | |||||||||||||||
| All leukemia | 16 | 1.09 | 1.00, 1.20 | 56.2 | 0.012 | 7 | 1.00 | 0.93, 1.09 | 67.0 | 0.006 | 3 | 1.05 | 0.96, 1.15 | 10.0 | 0.002 |
| Subtype | |||||||||||||||
| ALL | 9 | 1.05 | 0.96, 1.16 | 34.7 | 0.005 | 3 | 1.02 | 0.99, 1.05 | 0.0 | 0.000 | 1 | 1.00 | 0.92, 1.09 | — | 0.000 |
| AML | 5 | 1.09 | 0.86, 1.38 | 70.0 | 0.034 | 2 | 1.03 | 0.77, 1.38 | 87.7 | 0.039 | 1 | 1.25 | 1.02, 1.53 | — | 0.000 |
| Exposure timing | |||||||||||||||
| At birth | 5 | 0.98 | 0.90, 1.06 | 30.9 | 0.003 | 4 | 0.95 | 0.85, 1.05 | 52.4 | 0.006 | 1 | 1.15 | 0.78, 1.70 | — | 0.000 |
| At diagnosis | 14 | 1.32 | 1.12, 1.55 | 50.7 | 0.033 | 3 | 1.27 | 0.95, 1.71 | 81.0 | 0.049 | 2 | 1.05 | 0.94, 1.17 | 24.6 | 0.004 |
| Region | |||||||||||||||
| Asia | 1 | 1.27 | 0.51, 3.17 | — | 0.000 | — | — | ||||||||
| Europe | 9 | 1.25 | 1.05, 1.49 | 50.4 | 0.026 | 3 | 1.05 | 0.87, 1.25 | 63.8 | 0.017 | 1 | 1.05 | 0.95, 1.17 | — | 0.000 |
| North America | 6 | 1.02 | 0.89, 1.16 | 65.4 | 0.014 | 4 | 0.98 | 0.84, 1.15 | 74.9 | 0.017 | 2 | 1.09 | 0.72, 1.64 | 17.4 | 0.032 |
| Benzene | |||||||||||||||
| All leukemia | 7 | 1.27 | 1.03, 1.56 | 52.4 | 0.043 | 4 | 1.39 | 1.03, 1.87 | 27.9 | 0.035 | 2 | 1.08 | 0.64, 1.82 | 0.0 | 0.000 |
| Subtype | |||||||||||||||
| ALL | 7 | 1.09 | 0.88, 1.36 | 51.8 | 0.034 | 3 | 1.19 | 1.00, 1.40 | 0.0 | 0.000 | 1 | 0.69 | 0.27, 1.78 | — | 0.000 |
| AML | 5 | 1.84 | 1.31, 2.59 | 0.0 | 0.000 | 2 | 3.21 | 1.39, 7.42 | 0.0 | 0.000 | 1 | 0.43 | 0.04, 4.79 | — | 0.000 |
| Exposure timing | |||||||||||||||
| At birth | 3 | 1.21 | 1.04, 1.41 | 0.0 | 0.000 | 3 | 1.22 | 1.03, 1.43 | 0.0 | 0.000 | 1 | 1.14 | 0.63, 2.08 | — | 0.000 |
| At diagnosis | 4 | 1.36 | 0.92, 2.00 | 65.2 | 0.125 | 1 | 3.30 | 1.03, 10.59 | — | 0.000 | 1 | 0.90 | 0.31, 2.60 | — | 0.000 |
| Region | |||||||||||||||
| Asia | — | — | — | ||||||||||||
| Europe | 4 | 1.36 | 0.92, 2.00 | 65.2 | 0.125 | 1 | 3.30 | 1.03, 10.59 | — | 0.000 | 1 | 0.90 | 0.31, 2.60 | — | 0.000 |
| North America | 3 | 1.21 | 1.04, 1.41 | 0.0 | 0.000 | 3 | 1.22 | 1.03, 1.43 | 0.0 | 0.000 | 1 | 1.14 | 0.63, 2.08 | — | 0.000 |
| All leukemia | 8 | 1.04 | 0.90, 1.19 | 55.5 | 0.023 | 4 | 1.03 | 0.90, 1.18 | 14.9 | 0.004 | 1 | 0.89 | 0.42, 1.89 | — | 0.000 |
| Subtype | |||||||||||||||
| ALL | 4 | 1.02 | 0.89, 1.18 | 55.6 | 0.011 | 2 | 1.10 | 0.92, 1.32 | 46.2 | 0.008 | — | ||||
| AML | 4 | 0.97 | 0.79, 1.19 | 0.0 | 0.000 | 2 | 0.86 | 0.60, 1.23 | 0.0 | 0.000 | — | ||||
| Exposure timing | |||||||||||||||
| At birth | 4 | 1.07 | 0.96, 1.19 | 0.0 | 0.000 | 4 | 1.03 | 0.90, 1.18 | 14.9 | 0.004 | 1 | 0.89 | 0.42, 1.89 | — | 0.000 |
| At diagnosis | 4 | 1.17 | 0.82, 1.67 | 74.9 | 0.093 | — | — | ||||||||
| Region | |||||||||||||||
| Asia | 1 | 2.29 | 1.44, 3.64 | — | 0.000 | — | — | ||||||||
| Europe | 4 | 0.91 | 0.82, 1.00 | 0.0 | 0.000 | 1 | 0.79 | 0.52, 1.20 | — | 0.000 | — | ||||
| North America | 3 | 1.06 | 0.95, 1.18 | 0.0 | 0.000 | 3 | 1.06 | 0.94, 1.19 | 1.7 | 0.000 | 1 | 0.89 | 0.42, 1.89 | — | 0.000 |
Note: —, data not available; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CI, confidence interval; , I-squared statistic; RR, risk ratio; , tau-squared statistic.
Summary risk ratios (RRs) for association of childhood leukemia with particulate matter () and 1,3-butadiene comparing the highest versus the lowest exposure categories for all studies and stratified by age at diagnosis, leukemia subtype, exposure timing, and region.
| All children | Preschool children ( | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indicator | RR | 95% CI | RR | 95% CI | RR | 95% CI | |||||||||
| All leukemia | 3 | 1.05 | 0.94, 1.16 | 0.0 | 0.000 | 3 | 1.04 | 0.94, 1.16 | 0.0 | 0.000 | — | ||||
| Subtype | |||||||||||||||
| ALL | 2 | 1.11 | 0.95, 1.31 | 0.0 | 0.000 | 2 | 1.11 | 0.95, 1.31 | 0.0 | 0.000 | — | ||||
| AML | 2 | 1.00 | 0.87, 1.13 | 0.0 | 0.000 | 2 | 1.00 | 0.87, 1.13 | 0.0 | 0.000 | — | ||||
| Exposure timing | |||||||||||||||
| At birth | 3 | 1.05 | 0.94, 1.16 | 0.0 | 0.000 | 3 | 1.04 | 0.94, 1.16 | 0.0 | 0.000 | — | ||||
| At diagnosis | — | — | — | ||||||||||||
| Region | |||||||||||||||
| Europe | 1 | 1.00 | 0.72, 1.39 | — | 0.000 | 1 | 0.94 | 0.62, 1.43 | — | 0.000 | — | ||||
| North America | 2 | 1.05 | 0.94, 1.17 | 0.0 | 0.000 | 2 | 1.05 | 0.94, 1.17 | 0.0 | 0.000 | — | ||||
| All leukemia | 2 | 1.20 | 0.70, 2.04 | 43.5 | 0.075 | 2 | 1.09 | 0.66, 1.80 | 12.3 | 0.028 | 1 | 1.50 | 0.48, 4.70 | — | 0.000 |
| Subtype | |||||||||||||||
| ALL | 1 | 1.45 | 0.73, 2.87 | — | 0.000 | 1 | 1.50 | 0.52, 4.33 | — | 0.000 | 1 | 1.39 | 0.54, 3.57 | — | 0.000 |
| AML | 1 | 1.30 | 0.41, 4.14 | — | 0.000 | 1 | 1.21 | 0.18, 8.16 | — | 0.000 | 1 | 1.18 | 0.25, 5.56 | — | 0.000 |
| Exposure timing | |||||||||||||||
| At birth | 1 | 1.00 | 0.70, 1.42 | — | 0.000 | 1 | 0.97 | 0.62, 1.51 | — | 0.000 | — | ||||
| At diagnosis | 1 | 1.80 | 0.82, 3.97 | — | 0.000 | 1 | 1.90 | 0.60, 6.01 | — | 0.000 | 1 | 1.50 | 0.48, 4.70 | — | 0.000 |
| Region | |||||||||||||||
| Europe | 2 | 1.20 | 0.70, 2.04 | 43.5 | 0.075 | 2 | 1.09 | 0.66, 1.80 | 12.3 | 0.028 | 1 | 1.50 | 0.48, 4.70 | — | 0.000 |
| North America | — | — | — | ||||||||||||
| 1,3—Butadiene | |||||||||||||||
| All leukemia | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | — | ||||
| Subtype | |||||||||||||||
| ALL | 2 | 1.31 | 1.11, 1.54 | 0.0 | 0.000 | 2 | 1.31 | 1.11, 1.54 | 0.0 | 0.000 | — | ||||
| AML | 1 | 2.35 | 1.02, 5.40 | — | 0.000 | 1 | 2.35 | 1.02, 5.40 | — | 0.000 | — | ||||
| Exposure timing | |||||||||||||||
| At birth | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | |||||
| At diagnosis | — | — | |||||||||||||
| Region | |||||||||||||||
| Europe | — | — | — | ||||||||||||
| North America | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | 2 | 1.45 | 1.08, 1.95 | 28.0 | 0.025 | — | ||||
Note: —, data not available; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CI, confidence interval; , I-squared statistic; RR, risk ratio; , tau-squared statistic.
Figure 3.Dose–response meta-analysis of childhood leukemia risk from traffic indicators using (A) vehicles per day count (Langholz et al. 2002; Pearson et al. 2000; Raaschou-Nielsen et al. 2001, Reynolds et al. 2004), (B) road density in (Houot et al. 2015; Magnani et al. 2016; Reynolds et al. 2004), and (C) residential distance from a major road in meters (Abdul Rahman et al. 2008; Badaloni et al. 2013; Crosignani et al. 2004; Harrison et al. 1999; Houot et al. 2015; Spycher et al. 2015). Spline curve (black solid line) with 95% confidence limits (gray dashed lines). RR, risk ratio.
Figure 4.Dose–response meta-analysis of childhood leukemia risk from benzene exposure for (A) all leukemias (Crosignani et al. 2004; Heck et al. 2014; Houot et al. 2015; Janitz et al. 2017; Raaschou-Nielsen et al. 2018; Vinceti et al. 2012), (B) acute lymphoblastic leukemia only (Crosignani et al. 2004; Heck et al. 2014; Houot et al. 2015; Janitz et al. 2017; Raaschou-Nielsen et al. 2018; Vinceti et al. 2012), and (C) acute myeloid leukemia only (Heck et al. 2014; Houot et al. 2015; Janitz et al. 2017; Raaschou-Nielsen et al. 2018; Vinceti et al. 2012). Spline curve (black solid line) with 95% confidence limits (gray dashed lines). RR, risk ratio.
Figure 5.Dose–response meta-analysis of childhood leukemia risk from exposure for (A) all leukemias (Badaloni et al. 2013; Feychting et al. 1998; Heck et al. 2014; Houot et al. 2015; Janitz et al. 2016; Weng et al. 2008), (B) acute lymphoblastic leukemia only (Heck et al. 2014; Houot et al. 2015; Janitz et al. 2016), and (C) acute myeloid leukemia only (Heck et al. 2014; Houot et al. 2015; Janitz et al. 2016). Spline curve (black solid line) with 95% confidence limits (gray dashed lines). RR, risk ratio.